redalpine Closes €222.53M RAC VIII Fund for 20 European Startups

Swiss venture capital firm redalpine has closed its eighth early-stage fund, redalpine Capital VIII, at €222.53 million ($250 million) — a new record for the Zurich-based investor and a signal that capital is still flowing to European deep tech. The firm said the fund was oversubscribed, drawing both returning and first-time limited partners.

The new investors joining the vehicle are Aviva Investors, Flexstone Partners and KfW. The close marks a step up from redalpine Capital VII, which the firm closed at over €179 million in August 2024.

"Twenty years ago, we started redalpine with the conviction that the most important companies would emerge where software and science meet. That belief hasn't changed. With RAC VIII, we're excited to keep backing these founders early, before the opportunity is obvious," said Dr. Michael Sidler, Founding Partner at redalpine.

What will the fund actually do?

RAC VIII will back approximately 20 early-stage companies across Europe, chosen from a pool of more than 5,000 companies the firm screens every year. Investment tickets will range from €890k ($1 million) to €13.35 million ($15 million), with Seed and Series A rounds as the primary target.

The first portfolio companies are already taking shape:

• Enact Intelligence, developing force intelligence technology for robotics
• Helical, building a virtual AI lab for reproducible drug discovery
• Arlequin AI, working on a new AI architecture to protect critical systems

That's roughly €11 million per company if the fund deploys fully across 20 bets, concentrated in the software-plus-science niche redalpine has occupied since its founding.

Why did Aviva Investors write a check?

Cynthia Chen, Head of FinTech at Aviva Investors, said: "redalpine has a proven track record in backing fantastic European businesses that are at the forefront of technology and scientific innovation. At a time when global VC markets are competing more intensely than ever for investor capital, we are thrilled to partner with the team at redalpine and believe it can help us gain greater access to support some of the most exciting, high-growth, disruptive and innovative start-ups across the UK and Europe."

Chen's framing matters: institutional capital is chasing differentiated access in a crowded fundraising market, and redalpine's science-heavy pipeline is the pitch.

Does the firm have the receipts?

Founded in Zurich in 2006 by molecular biologist Dr. Sidler and software entrepreneur Peter Niederhauser, redalpine has kept a tight focus on businesses combining software with science. Half of its investment team are trained scientists — biologists, physicists and engineers — which the firm says gives it the technical depth to evaluate complex technologies at the earliest stages. Past bets span AI, fusion energy, robotics and biotechnology.

The numbers back the positioning. The portfolio now counts more than 100 companies, including Mistral AI, Proxima Fusion, N26, Basecamp Research and Microagi. Companies backed by the predecessor RAC VII fund, closed in 2024, have collectively raised over €970 million ($1.1 billion) in follow-on funding. Since 2023, the firm has exited 12 portfolio companies.

In plain terms: the previous fund is already returning proof points, which makes the oversubscription on this one easier to explain.

What's the bigger play here?

redalpine operates from offices in Zug, Berlin and London, with a presence in Silicon Valley, and now manages over €1.24 billion ($1.4 billion) in assets. RAC VIII is the eighth iteration of its early-stage vehicle and sits within a multi-stage platform designed to support founders from Seed all the way through to IPO.

The firm's stated ambition goes beyond returns. redalpine says it wants to bring more of the value created by European technology companies back to European investors, including pension funds — a direct answer to the long-running complaint that Europe's biggest wins end up enriching outside capital.

With €222.53 million now committed and three portfolio companies already in place, RAC VIII gives redalpine fresh ammunition to keep buying into European deep tech before the opportunity is obvious to everyone else.